90Y-PET for the assessment of microsphere biodistribution after selective internal radiotherapy

Nuclear Medicine Communications

Volumn 33, Issue 2, 2012, Pages 198-204

  Bagni, Oreste ^a   D'Arienzo, Marco ^b,c   Chiaramida, Paola ^d   Chiacchiararelli, Laura ^b   Cannas, Pina ^a   D'Agostini, Antonio ^a   Cianni, Roberto ^a   Salvatori, Rita ^a   Scopinaro, Francesco ^b  

^a SANTA MARIA GORETTI HOSPITAL   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c ENEA   (Italy)

^d GE HEALTHCARE   (United Kingdom)

Author keywords

90Y; microspheres; PET imaging; radioembolization; radionuclide therapy; selective internal radiotherapy

Indexed keywords

FLUORODEOXYGLUCOSE F 18; MICROSPHERE; TECHNETIUM 99M; YTTRIUM 90; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT; TECHNETIUM COMPLEX; YTTRIUM;

ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COLORECTAL CARCINOMA; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DRUG DISTRIBUTION; FEMALE; HUMAN; IMAGING SYSTEM; LIVER METASTASIS; MALE; RADIATION DOSE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; COMPARATIVE STUDY; FEASIBILITY STUDY; LIVER; LIVER TUMOR; METABOLISM; METHODOLOGY; MIDDLE AGED; POSITRON EMISSION TOMOGRAPHY; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; THREE DIMENSIONAL IMAGING; TISSUE DISTRIBUTION;

FEASIBILITY STUDIES; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGING, THREE-DIMENSIONAL; LIVER; LIVER NEOPLASMS; MALE; MICROSPHERES; MIDDLE AGED; ORGANOTECHNETIUM COMPOUNDS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; YTTRIUM RADIOISOTOPES;

EID: 84855203417     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e32834dfa58     Document Type: Article

References (24)

1. Van Hazel G, Blackwell A, Anderson J, Price D, Moroz P, Bower G, et al. Randomised phase trial of SIR-spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer. J Surg Oncol 2004; 1:78-85. (Pubitemid 39536508)
2. Goin JE, Salem R, Carr BI, Dancey JE, Soulen MC, Geschwind JF, et al. Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: factors associated with liver toxicities. J Vasc Interv Radiol 2005; 16:205-213. (Pubitemid 40322293)
3. Gulec SA, Fong Y. Yttrium 90 microsphere selective internal radiation treatment of hepatic colorectal metastases. Arch Surg 2007; 142:675-682. (Pubitemid 47080453)
4. Kennedy A, Nag S, Salem R, Murthy R, McEwan AJ, Nutting C, et al. Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium. Int J Radiat Oncol Biol Phys 2007; 1:13-23. (Pubitemid 46589861)
5. Campbell AM, Bailey I, Burton M. Analysis of the distribution of intra-arterial microspheres in human liver following hepatic yttrium-90 microsphere therapy. Phys Med Biol 2000; 45:1023-1033. (Pubitemid 30196393)
6. Ahmadzadehfar H, Sabet A, Biermann K, Muckle M, Brockmann H, Kuhl C, et al. The significance of 99mTc-MAA SPECT/CT liver perfusion imaging in treatment planning for 90Y microsphere selective internal radiation treatment. J Nucl Med 2010; 51:1206-1212. doi: 10.2967/jnumed.109.074559.
7. 90Y-microsphere injection for immediate treatment monitoring and further therapy planning for radioembolization. Eur J Nucl Med Mol Imaging 2011; 38:1281-1288.
8. Sebastian AJ, Szyszko T, AL-Nahhas A, Nijran K, Tait NP. Evaluation of hepatic angiography procedures and bremsstrahlung imaging in selective internal radiation therapy: a two-year single-center experience. Cardiovascr Intervent Radiol 2008; 31:643-649.
9. Shen S, DeNardo GL, DeNardo SJ. Quantitative bremsstrahlung imaging of yttrium-90 using a Wiener filter. Med Phys 1994; 21:1409-1417. (Pubitemid 24307958)
10. 90Y SPECT based on experimental phantom studies. Phys Med Biol 2008; 53:5689-5703.
11. 90Y microspheres (medical radiology/diagnostic imaging) Berlin: Springer, 2008; p. 86.
12. 90Y therapy of liver cancer. Technol Cancer Res Treat 2010; 9:253-262.
13. 90Sr. Appl Radiat Isot 2007; 65:318-327. (Pubitemid 44960818)
14. Nickles RJ, Roberts AD, Nye JA, Converse AK, Barnhart TE, Avila-Rodirguez MA. Assaying and PET imaging of yttrium-90: l > > 34 ppm > 0. IEEE Nucl Sci Symp Rec 2004; 6:3412-3414. (Pubitemid 41147680)
15. 90Y PET. J Nucl Med 2010; 51:1969-1973.
16. 90Y Time-of-flight PET/MR on a hybrid scanner following liver radioembolisation (SIRT). Eur J Nucl Med Mol Imaging 2011; 38:1744-1745. doi: 10.1007/s00259-011-1792-2.
17. Lhommel R, Goffette P, Van den Eynde M, Jamar F, Pauwels S, Bilbao J, et al. Yttrium-90 TOF PET scan demonstrates high-resolution biodistribution after liver SIRT. Eur J Nucl Med Mol Imaging 2009; 36:1696.
18. 90Y biodistribution after selective internal radiotherapy (SIRT) of liver metastases. Eur J Nucl Med Mol Imaging 2010; 37:407-408.
19. 90Y permits hepatic localization of microspheres using routine PET: proof of concept. J Nucl Med 2010; 52:72.
20. Lhommel R, van Elmbt L, Goffette P, Van den Eynde M, Jamar F, Pauwels S, et al. Feasibility of 90Y TOF PET-based dosimetry in liver metastasis therapy using SIR-Spheres. Eur J Nucl Med Mol Imaging 2010; 37:1654-1662.
21. National Electrical Manufacturers Association. Standards Publication NU-2-2007: performance measurements of positron emission tomography. Rosslyn: National Electrical Manufacturers Association; 2007.
22. National Electrical Manufacturers Association. Standards Publication NU-2-2001: performance measurements of positron emission tomography. Rosslyn: National Electrical Manufacturers Association; 2001.
23. Rault E, Clementel E, Vandenberghe S, D'Asseler Y, Van Holen R De Beenhouwer J, et al. Comparison of yttrium-90 SPECT and PET images Abstract. J Nucl Med 2010; 51 (Suppl 2):125.
24. Walrand S, Flux GD, Konijnenberg MW, Valkema R, Krenning EP, Lhommel R, et al. Dosimetry of yttrium-labelled radiopharmaceuticals for internal therapy: 86Y or 90Y imaging? Eur J Nucl Med Mol Imaging 2011; 38 (Suppl 1):S57-S68.